Xiaobo Li
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 2%
- interferon and immune responses
- Immune cells in cancer
Papers in
-
- RNA modifications and cancer 20
- Circular RNAs in diseases 20
- RNA Research and Splicing 8
-
- Cancer-related molecular mechanisms research 35
- MicroRNA in disease regulation 19
- Co-authors
- Tianzhen Wang (12 shared papers)Guangyu Wang (12 shared papers)Tongsen Zheng (9 shared papers)Yuanyuan Zhu (5 shared papers)Shenshen Wu (19 shared papers)Rui Chen (19 shared papers)Xiang An (3 shared papers)Xiao Zhang (2 shared papers)
- Journals
- Cancer Letters (5 papers)Frontiers in Immunology (4 papers)Tumor Biology (4 papers)Frontiers in Oncology (4 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Xiaobo Li
145 papers receiving 5.4k citations
Xiaobo Li's Hit Papers
Peers
Comparison fields: 5 of 137
- Cancer Research 1.6k
- Immunology 967
- Molecular Biology 2.6k
- Oncology 883
- Infectious Diseases 359
Countries citing papers authored by Xiaobo Li
This map shows the geographic impact of Xiaobo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Li more than expected).
Fields of papers citing papers by Xiaobo Li
This network shows the impact of papers produced by Xiaobo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Li. The network helps show where Xiaobo Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Hit paper breakdown → | 2020 | 502 |
| 2 | STING: a master regulator in the cancer-immunity cycle Hit paper breakdown → | 2019 | 319 |
| 3 | 2016 | 171 | |
| 4 | 2016 | 167 | |
| 5 | 2019 | 154 | |
| 6 | 2012 | 153 | |
| 7 | 2015 | 149 | |
| 8 | 2019 | 147 | |
| 9 | 2013 | 133 | |
| 10 | 2018 | 130 | |
| 11 | 2014 | 128 | |
| 12 | 2021 | 118 | |
| 13 | 2012 | 75 | |
| 14 | 2015 | 74 | |
| 15 | 2016 | 70 | |
| 16 | 2012 | 70 | |
| 17 | 2015 | 69 | |
| 18 | 2016 | 69 | |
| 19 | 2023 | 67 | |
| 20 | 2019 | 66 |
About Xiaobo Li
Xiaobo Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 151 papers that have together received 5.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (35 papers), RNA modifications and cancer (20 papers), Circular RNAs in diseases (20 papers), MicroRNA in disease regulation (19 papers), interferon and immune responses (14 papers), RNA Research and Splicing (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Cancer Research (1.6k citations), Immunology (967 citations), Molecular Biology (2.6k citations), Oncology (883 citations) and Infectious Diseases (359 citations). Xiaobo Li has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Tianzhen Wang, Guangyu Wang, Tongsen Zheng, Yuanyuan Zhu, Shenshen Wu, Rui Chen, Xiang An, Xiao Zhang, Yu Qiao and Xi Liu. Their work appears in journals such as Cancer Letters, Frontiers in Immunology, Tumor Biology, Frontiers in Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.